Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: Results from a population-based study

Thorax

Volumn 69, Issue 8, 2014, Pages 709-717

  Tan, W C ^a   Bourbeau, J ^b   Hernandez, P ^c   Chapman, K R ^d   Cowie, R ^e   Fitzgerald, J M ^a   Marciniuk, D D ^f   Maltais, F ^g   Buist, A S ^h   O'Donnell, D E ⁱ   Sin, D D ^a   Aaron, S D ^j  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF SASKATCHEWAN   (Canada)

^g LAVAL UNIVERSITY   (Canada)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ QUEEN S UNIVERSITY   (Canada)

^j OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTITUSSIVE AGENT; BRONCHODILATING AGENT; DECONGESTIVE AGENT; STEROID;

ADULT; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COUGHING; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; DYSPNEA; EXACERBATION LIKE RESPIRATORY SYMPTOM; FEMALE; GENDER; HEALTH CARE UTILIZATION; HUMAN; INCOME; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; RISK FACTOR; SHORT FORM 12; SOCIAL ASPECT; SOCIAL BEHAVIOR; SPUTUM; WHEEZING;

ASTHMA EPIDEMIOLOGY; CLINICAL EPIDEMIOLOGY; COPD EXACERBATIONS;

ACTIVITIES OF DAILY LIVING; ACUTE DISEASE; ADULT; AGED; AIRWAY OBSTRUCTION; ASTHMA; BRONCHITIS; CANADA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; URBAN POPULATION;

EID: 84904036299     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-205048     Document Type: Article

References (35)

1. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007;29:1224-38. (Pubitemid 46895385)
2. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.
3. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117:398S-401S. (Pubitemid 30314474)
4. GOLD. Global Strategy for Diagnosis, Management, and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. 2011. http://www.goldcopd.org/[accessed 24 Mar 2014].
5. Boulet LP, FitzGerald JM, Levy ML, et al. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J 2012;39:1220-9.
6. Jones PW, Nadeau G, Small M, et al. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Respir Med 2013;108:129-35.
7. Kessler R, Stahl E, Vogelmeier C, et al. Patient understanding, detection, and experience of COPD exacerbations: An observational, interview-based study. Chest 2006;130:133-42. (Pubitemid 44116851)
8. Spencer S, Calverley PM, Burge PS, et al. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004;23:698-702. (Pubitemid 38618138)
9. Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J 2005;26:234-41. (Pubitemid 41079066)
10. Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-52. (Pubitemid 35178607)
11. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 2001;164:358-64. (Pubitemid 32778199)
12. Wouters EF. The burden of COPD in The Netherlands: results from the Confronting COPD survey. Respir Med 2003;97(Suppl C):S51-9. (Pubitemid 36266870)
13. de Oca MM, Halbert RJ, Lopez MV, et al. The chronic bronchitis phenotype in subjects with and without COPD: The PLATINO study. Eur Respir J 2012;40:28-36.
14. Lamprecht B, Vanfleteren LE, Studnicka M, et al. Sex-related differences in respiratory symptoms: results from the BOLD Study. Eur Respir J 2013;42:858-60.
15. Tan WC, Bourbeau J, Hernandez P, et al. Bronchodilator responsiveness and reported respiratory symptoms in an adult population. PLoS ONE 2013;8:e58932.
16. Miravitlles M, de la Roza C, Morera J, et al. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir Med 2006;100:1973-80. (Pubitemid 44490285)
17. Mallia P, Message SD, Gielen V, et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 2010;183:734-42.
18. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355-65.
19. Graham NM. The epidemiology of acute respiratory infections in children and adults: A global perspective. Epidemiol Rev 1990;12:149-78.
20. Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122.
21. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet 2007;370:741-50. (Pubitemid 47321907)
22. Tan WC, Bourbeau J, FitzGerald JM, et al. Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada. Int J Tuberc Lung Dis 2011;15:1691-8.
23. Fletcher CM, Elmes PC, Fairbairn AS, et al. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959;2:257-66.
24. Ware JE Jr, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: A user's manual. Boston: The Health Institute, New England Medical Centre, 1994.
25. Barr RG, Berkowitz EA, Bigazzi F, et al. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD 2012;9:151-9.
26. Wedzicha JA, Brill SE, Allinson JP, et al. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med 2013;11:181.
27. Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: An update. Transl Res 2013;162:208-18.
28. Donaldson GC, Wedzicha JA. Deprivation, winter season, and COPD exacerbations. Prim Care Respir J 2013;22:264-5.
29. Damarla M, Celli BR, Mullerova HX, et al. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care 2006;51:1120-4.
30. Starren ES, Roberts NJ, Tahir M, et al. A centralised respiratory diagnostic service for primary care: A 4-year audit. Prim Care Respir J 2012;21:180-6.
31. Seemungal TA, Harper-Owen R, Bhowmik A, et al. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2000;16:677-83.
32. Peacock JL, Anderson HR, Bremner SA, et al. Outdoor air pollution and respiratory health in patients with COPD. Thorax 2011;66:591-6.
33. Sint T, Donohue JF, Ghio AJ. Ambient air pollution particles and the acute exacerbation of chronic obstructive pulmonary disease. Inhal Toxicol 2008;20:25-9. (Pubitemid 351194919)
34. Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1608-13. (Pubitemid 30329036)
35. Aaron SD, Donaldson GC, Whitmore GA, et al. Time course and pattern of COPD exacerbation onset. Thorax 2011;67:238-43.